Literature DB >> 7461024

Effect of dose on bioavailability of oral digoxin.

H R Ochs, G Bodem, D J Greenblatt.   

Abstract

Nine healthy volunteers received single 0.25, 0.5, 1.0, 1.5, and 2.0 mg doses of oral digoxin tablets in random sequence on five occasions separated by at least 4 weeks. Urinary excretion of immunoassayable digoxin was determined from 8 consecutive 24 h urine samples collected after each dose. Mean values of cumulative urinary excretion of digoxin at the 5 doses were: 40.9, 35.6, 36.4, 34.1, and 33.5% of the dose (F = 0.64; d.f. = 4.32; N.S.). Mean values of urinary excretion half-life were: 2.48, 2.03, 2.20, 2.07, and 1.87 days (F = 2.87; d.f. = 4.32; p = 0. 05). Thus, the bioavailability of orally administered digoxin tablets in healthy volunteers is dose-independent over an 8-fold range of doses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461024     DOI: 10.1007/bf00558384

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Dose-independent pharmacokinetics of digoxin in humans.

Authors:  H R Ochs; D J Greenblatt; G Bodem; J S Harmatz
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

2.  Correlation of digoxin-tablet dissolution-rate with biological availability.

Authors:  J Lindenbaum; V P Butler; J E Murphy; R M Cresswell
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

3.  Evaluation of digoxin bioavailability in single-dose studies.

Authors:  D J Greenblatt; D W Duhme; J Koch-Weser; T W Smith
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Some considerations as to the determination and significance of biologic half-life.

Authors:  M Gibaldi; H Weintraub
Journal:  J Pharm Sci       Date:  1971-04       Impact factor: 3.534

5.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Assessment of methodology in single-dose studies of digoxin bioavailability.

Authors:  D J Greenblatt; D W Duhme; J Koch-Weser; T W Smith
Journal:  Pharmacology       Date:  1976       Impact factor: 2.547

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 8.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

  8 in total
  2 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Clinical implications of serum digoxin concentrations.

Authors:  H R Ochs; D J Greenblatt; J S Harmatz; G Bodem; H J Dengler
Journal:  Klin Wochenschr       Date:  1981-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.